Skip to main content
NewslettersWatchlist

Celldex Therapeutics(CLDX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria for Late-Breaking Presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2022

Globe Newswire - Thu May 19, 2022

HAMPTON, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing the Phase 1b study of barzolvolimab (CDX-0159) in patients with antihistamine refractory chronic spontaneous urticaria (CSU), has been accepted as a late-breaking electronic poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2022, being held July 1-3, 2022.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

globe investor
AI darling Nvidia’s market value surges closer to Apple
A Nvidia logo is seen on one of their products on display at their headquarters in Taipei, Taiwan May 31, 2023.
analysis
Tuesday’s TSX breakouts: This soaring utility stock enters deeply overbought territory
Wind turbines that make up a part of the Boralex Wind Farm in Lincoln Township, Niagara Peninsula in Ontario on Tuesday, July 17, 2018.
market news
Nasdaq closes above 17,000 for first time, powered by Nvidia
Traders work on the floor of the New York Stock Exchange during morning trading on May 24.
inside the market
What every Canadian investor needs to know today
FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26, 2024. REUTERS/Brendan McDermid/File Photo
market news
The close: TSX higher as commodity prices climb
inside the market
What every Canadian investor needs to know today
A person looks at an electronic stock board showing Japan's Nikkei 225 index at a securities firm Monday, May 27, 2024, in Tokyo. (AP Photo/Eugene Hoshiko)
opinion
Sinking ships and soaring stocks: A tale of caution for investors
Sam Sivarajan
cost of living
Behind the billion-dollar busts: key lessons for investors
BERKELEY, CALIFORNIA - AUGUST 09: A sign is posted on the exterior of a WeWork office on August 09, 2023 in Berkeley, California. New York-based workspace-sharing company WeWork says it has "substantial doubt" it can stay in business due to continued financial losses. (Photo by Justin Sullivan/Getty Images)

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).